Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011)

J Wang, M Sánchez-Roselló, JL Aceña… - Chemical …, 2014 - ACS Publications
1.1. Brief Historical Overview As expected from the fluorine position on the periodic table of
elements, it possesses some extreme properties, in particular, ultimate electronegativity and …

Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome …

T Venkatesan, DJ Levinthal, SE Tarbell… - …, 2019 - Wiley Online Library
The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the
development of these evidence‐based guidelines on the management of CVS in adults …

Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life

P Fernández-Ortega, MT Caloto, E Chirveches… - Supportive care in …, 2012 - Springer
Background Chemotherapy-induced nausea and vomiting (CINV) in cancer patients are
common symptoms most feared by patients. The aim of this study was to analyze the impact …

Evaluating the role of substance P in the growth of brain tumors

E Harford-Wright, KM Lewis, R Vink, MN Ghabriel - Neuroscience, 2014 - Elsevier
Recent research has investigated the expression and secretion of neuropeptides by tumors,
and the potential of these peptides to facilitate tumor growth and spread. In particular …

Acute care of cyclic vomiting syndrome and cannabinoid hyperemesis syndrome in the home and emergency department for: Special supplement/proceedings of 3rd …

DJ Levinthal, B Killian… - Neurogastroenterology & …, 2024 - Wiley Online Library
Background Cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome
(CHS) are both characterized by episodic, acute transitions from asymptomatic states to …

Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double …

LQ Yang, XC Sun, SK Qin, Y Cheng… - European Journal of …, 2017 - Wiley Online Library
The prevention of chemotherapy‐induced nausea and vomiting was one of the most
challenging supportive care issues in oncology, especially to highly emetogenic …

[HTML][HTML] The clinical research study for fosaprepitant to prevent chemotherapy-induced nausea and vomiting: A review

F Xue, X Liu, X Qi, J Zhou, Y Liu - Advances in Clinical and …, 2023 - advances.umw.edu.pl
In recent years, chemotherapy-induced nausea and vomiting (CINV) has become the most
common adverse effect of chemotherapy in oncology patients. The CINV may reduce the …

NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer

KM Lewis, E Harford-Wright, R Vink… - Anti-cancer …, 2013 - journals.lww.com
Emend, an NK1 antagonist, and dexamethasone are used to treat complications associated
with metastatic brain tumours and their treatment. It has been suggested that these agents …

[HTML][HTML] Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments

C Vieira, R Bergantim, E Madureira… - Porto Biomedical …, 2023 - journals.lww.com
Chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and
vomiting (RINV) strongly affect the quality of life of patients with cancer. Inadequate …

Prodrug approaches to drug delivery

L Hu - Drug delivery: Principles and applications, 2016 - Wiley Online Library
This chapter focuses on the various prodrug approaches that have been used to overcome
many of the pharmaceutical and pharmacokinetic barriers that hinder the optimal delivery of …